Data regarding overdoses of trimetazidine are not readily available.L33015 Treat overdoses with symptomatic and supportive therapy.L33015
The oral LD50 in rats is 1700 mg/kg, and in mice is 1550 mg/kg.L33025 The subcutaneous LD50 in rats is 1500 mg/kg, and in mice is 410 mg/kg.L33025
Trimetazidine is a piperazine derivative indicated for the symptomatic treatment of stable angina pectoris in patients inadequately controlled or intolerant to first line therapies.L33015 Trimetazidine has been studied as a treatment for angina pectoris since the late 1960s.A233255,A233260
Acidic conditions, caused by anaerobic metabolism and fatty acid oxidation, in response to myocardial ischemia, activate sodium-hydrogen and sodium-calcium antiport systems.A233215 The increased intracellular calcium decreases contractility.A233215 It is hypothesized that trimetazidine inhibits 3-ketoacyl coenzyme A thiolase, which decreases fatty acid oxidation but not glucose metabolism, preventing the acidic conditions that exacerbate ischemic injury.A7688,L33020 However, evidence for this mechanism is controversial.A233215
Trimetazidine is not FDA approved. However, it has been approved in France since 1978.L33020
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Metoclopramide | The risk or severity of adverse effects can be increased when Metoclopramide is combined with Trimetazidine. |